You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for PURINETHOL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PURINETHOL

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Get Started Free Het``Dki@HRYYUnFXBBa@@ ⤷  Get Started Free
Specs ⤷  Get Started Free AG-670/31547064 ⤷  Get Started Free
MP Biomedicals ⤷  Get Started Free 214184 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 667490 ⤷  Get Started Free
MP Biomedicals ⤷  Get Started Free 102263 ⤷  Get Started Free
ISpharm ⤷  Get Started Free I14-1716 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PURINETHOL (Mercaptopurine)

Last updated: July 28, 2025


Introduction

Purinethol (mercaptopurine) is a cornerstone antineoplastic agent used predominantly in the treatment of acute lymphoblastic leukemia (ALL). As a purine analog, it interrupts DNA and RNA synthesis in rapidly dividing cells. Ensuring a reliable, quality supply chain for bulk mercaptopurine API is critical for pharmaceutical manufacturers and healthcare providers, especially given its narrow therapeutic index and importance in chemotherapy protocols. This report examines the primary sources, manufacturing landscape, and considerations for sourcing mercaptopurine API.


Overview of Mercaptopurine API

Mercaptopurine (6-mercaptopurine) was developed in the 1950s and remains a vital component in pediatric and adult leukemia treatment regimens. The API's synthesis involves complex chemical processes, often focusing on purity, stability, and compliance with international pharmaceutical standards (e.g., USP, EP, JP).

The global demand for mercaptopurine API is driven by oncology markets, particularly in North America, Europe, and parts of Asia. Supply chain integrity depends on sourcing from reputable manufacturers adhering to Good Manufacturing Practices (GMP).


Leading API Manufacturers for Mercaptopurine

1. Major Global Suppliers

  • Taj Pharmaceuticals (India):
    Known for robust API manufacturing, Taj Pharmaceuticals offers mercaptopurine API compliant with international standards. Their facilities have GMP certification, and they supply to multiple global markets. The company emphasizes consistent quality, competitive pricing, and reliable logistics.

  • Hetero Labs (India):
    Hetero is a prominent player in the generic API space, including mercaptopurine. They have a dedicated R&D division focused on process optimization and quality assurance, supporting market demand with a comprehensive portfolio.

  • Sun Pharmaceutical Industries (India):
    With multiple GMP-certified manufacturing sites, Sun Pharma supplies mercaptopurine API through strategic partnerships and direct procurement channels, emphasizing regulatory compliance and supply stability.

  • Mylan (Global):
    Now part of Viatris, Mylan has historically supplied various oncology APIs, including mercaptopurine, with a focus on high-quality standards and extensive distribution networks.

  • APIs from China (Various Manufacturers):
    Chinese API producers such as Zhejiang medicine and Hunan Zijin Pharmaceutical have expanded their product profiles to include mercaptopurine. While offering cost advantages, regulatory due diligence is critical to ensure compliance with international standards.

2. Niche and Specialized Suppliers

  • Siegfried AG (Germany):
    Known for high-purity pharmaceutical ingredients, Siegfried supplies mercaptopurine API to European markets with strong adherence to GMP and EMA guidelines.

  • Dr. Reddy’s Laboratories (India):
    Offers comprehensive API portfolios, including mercaptopurine, with an emphasis on quality control and regulatory approvals across multiple regions.


Regional Sourcing Dynamics

Asia-Pacific

The Asia-Pacific region dominates API manufacturing for mercaptopurine owing to lower labor and production costs, high manufacturing capacity, and rising exports from Indian and Chinese facilities. Indian manufacturers, such as Jubilant and Natco Pharma, are key suppliers, often achieving GMP certification aligned with global standards.

Europe and North America

European and North American markets primarily depend on established, globally recognized API manufacturers such as Siegfried and Mylan. These providers offer high-quality APIs certified for strict regulatory environments and are preferred for clinical trials and regulated markets requiring comprehensive documentation.


Quality and Regulatory Considerations

  • GMP Compliance:
    Any reputable API supplier must possess valid GMP certificates aligned with regional agencies (FDA, EMA, MHRA). This ensures consistent quality, batch-to-batch uniformity, and compliance with pharmacopeial standards.

  • Pharmacopoeial Standards:
    API sources should meet USP, EP, or JP standards relevant for usage in licensed pharmaceuticals. Analytical testing data, impurity profiles, and stability assessments are vital components for validation.

  • Supply Chain Stability:
    The COVID-19 pandemic exposed vulnerabilities in global API supply chains. Sourcing from multiple qualified vendors, preferably with manufacturing facilities in different regions, mitigates risks of shortages.


Supply Chain Challenges and Considerations

  • Price Volatility:
    API prices fluctuate based on raw material costs, regulatory changes, and geopolitical factors. Diversification of suppliers can protect against price surges.

  • Regulatory Approval Status:
    Always verify API manufacturers have necessary certifications and submit comprehensive Technical Transfer documentation for global markets.

  • Raw Material Sourcing:
    Mercaptopurine's synthesis involves specific chemical precursors. Securing quality raw materials from reliable suppliers is crucial to maintain API purity and potency.

  • Environmental and Ethical Standards:
    Ensure suppliers comply with environmental regulations and corporate social responsibility policies, especially when sourcing from regions with emerging regulatory frameworks.


Conclusion

Sourcing bulk mercaptopurine API involves navigating a complex landscape of reputable manufacturers, regional dynamics, quality standards, and supply chain risks. Indian manufacturers like Taj Pharmaceuticals and Hetero Labs currently dominate the global supply due to their scale, cost-efficiency, and quality compliance. European players such as Siegfried provide high-purity options for regulated markets. Chinese producers, expanding their capacities, offer cost-effective alternatives but require thorough validation.

Pharmaceutical companies must prioritize quality assurance, regulatory compliance, and supply stability in their sourcing strategies. Establishing relationships with multiple certified vendors across regions can mitigate risks and ensure uninterrupted access to this critical medicinal ingredient.


Key Takeaways

  • Indian API manufacturers are leading suppliers of mercaptopurine due to their extensive capacity and cost advantages.
  • Europe and North America rely on high-quality suppliers like Siegfried, with strict GMP compliance for regulated markets.
  • Supply chain resilience hinges on diversification, rigorous validation, and adherence to international standards.
  • Raw material quality, environmental compliance, and regulatory certifications are critical factors for API sourcing.
  • Ongoing geopolitical and pandemic-related disruptions necessitate proactive supplier management and contingency planning.

FAQs

1. Who are the top global suppliers of mercaptopurine API?
Leading suppliers include Taj Pharmaceuticals (India), Hetero Labs (India), Siegfried AG (Germany), and Mylan (Viatris). Chinese manufacturers are also increasing their market share.

2. What quality certifications should I verify when sourcing mercaptopurine APIs?
Ensure suppliers have GMP certificates compatible with regional authorities (FDA, EMA), and APIs meet pharmacopeial standards such as USP, EP, or JP.

3. How can I mitigate supply chain risks for mercaptopurine API?
Diversify vendors across regions, validate suppliers thoroughly, establish long-term agreements, and consider maintaining safety stock.

4. Are there regulatory restrictions on sourcing mercaptopurine from China?
While many Chinese suppliers meet international standards, due diligence including validation of certifications, inspection reports, and testing data is essential before procurement.

5. What are the main raw materials involved in mercaptopurine synthesis?
Synthesis involves purine precursors such as amino acids and specific intermediates. Sourcing high-quality raw materials is fundamental to ensuring API purity and efficacy.


References

[1] U.S. Pharmacopeia (USP). "Mercaptopurine." USP Monograph.
[2] European Pharmacopoeia (EP). Monograph on Mercaptopurine.
[3] "Global API Market Analysis," IQVIA, 2022.
[4] "Indian Bulk Drug Industry," Department of Pharmaceuticals, Government of India, 2022.
[5] "Chinese API Manufacturing Overview," China Pharma Report, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.